Björn Thorngren

All filings by Björn Thorngren on record concern Meds Apotek AB, in the capacity of chief executive. Over a trading history stretching from 22 September 2025 to 20 August 2026, the count stands at 24 filings.

Both buying and selling appear: 23 purchases worth €34k, against 1 sale worth €873k. On balance, insiders were net sellers of €839k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 23 purchases and no sales.

A typical purchase (the median) is worth €1,024. Relative to company size, the median is 0.0012% of market cap (6 purchases with a known value). Of 22 purchases, 2 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 75% of cases; the median change was +16.3%. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 20 August 2026 with an open-market purchase (€4,570) in Meds Apotek AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.